医学
曲妥珠单抗
曲妥珠单抗
内科学
肿瘤科
乳腺癌
人口
阶段(地层学)
胃肠病学
紫杉醇
佐剂
癌症
外科
生物
环境卫生
古生物学
作者
Sara M. Tolaney,Nabihah Tayob,Chau T. Dang,Denise A. Yardley,Steven J. Isakoff,Vicente Valero,Meredith Faggen,Therese M. Mulvey,Ron Bose,Jiani Hu,Douglas Weckstein,Antonio C. Wolff,Katherine E. Reeder‐Hayes,Hope S. Rugo,Bhuvaneswari Ramaswamy,Dan Sayam Zuckerman,Lowell L. Hart,Vijayakrishna K. Gadi,Michael Constantine,Kit Cheng
摘要
Among patients with stage I HER2+ BC, one year of adjuvant T-DM1 was associated with excellent 3-year iDFS, but was not associated with fewer CRT compared with TH.
科研通智能强力驱动
Strongly Powered by AbleSci AI